{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:31:06Z","timestamp":1791293466495,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1053\/j.gastro.2010.05.073","type":"journal-article","created":{"date-parts":[[2010,6,3]],"date-time":"2010-06-03T04:40:43Z","timestamp":1275540043000},"page":"953-964.e4","source":"Crossref","is-referenced-by-count":184,"title":["Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes"],"prefix":"10.1053","volume":"139","author":[{"given":"Isabel","family":"Fofana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie E.","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Grunert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Glauben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Fafi\u2013Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Soulier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Royer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Thumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Mee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"McKeating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Dragic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pessaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Stoll\u2013Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2010.05.073_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2010.05.073_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2008.11.010","article-title":"Treatment failure in hepatitis C: mechanisms of non-response","volume":"50","author":"Tai","year":"2009","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.05.073_bib3","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMoa0807650","article-title":"Telaprevir and peginterferon with or without ribavirin for chronic HCV infection","volume":"360","author":"Hezode","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2010.05.073_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature04083","article-title":"Hepatitis C and liver transplantation","volume":"436","author":"Brown","year":"2005","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2010.05.073_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrgastro.2009.92","article-title":"New and experimental therapies for HCV","volume":"6","author":"Pereira","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2010.05.073_bib6","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1136\/gut.2007.141630","article-title":"Hepatitis C virus entry: possible targets for therapy","volume":"57","author":"Timpe","year":"2008","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2010.05.073_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hep.22307","article-title":"Host neutralizing responses and pathogenesis of hepatitis C virus infection","volume":"48","author":"Zeisel","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.05.073_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.05.073_bib9","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2010.05.073_bib10","doi-asserted-by":"crossref","first-page":"41003","DOI":"10.1074\/jbc.M302267200","article-title":"Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate","volume":"278","author":"Barth","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1053\/j.gastro.2010.05.073_bib11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1053\/j.gastro.2010.05.073_bib12","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J"},{"key":"10.1053\/j.gastro.2010.05.073_bib13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2010.05.073_bib14","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"Ploss","year":"2009","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2010.05.073_bib15","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1128\/JVI.01504-09","article-title":"Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line","volume":"84","author":"Haid","year":"2010","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2010.05.073_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.21959","article-title":"Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies","volume":"47","author":"Timpe","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.05.073_bib17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1083\/jcb.141.7.1539","article-title":"Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin","volume":"141","author":"Furuse","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1053\/j.gastro.2010.05.073_bib18","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.23445","article-title":"Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations","volume":"51","author":"Krieger","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.05.073_bib19","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2010.05.073_bib20","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1128\/JVI.00246-09","article-title":"Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells","volume":"83","author":"Mee","year":"2009","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2010.05.073_bib21","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.02262-08","article-title":"Residues in a highly conserved claudin-1 motif are required for hepatitis C virus entry and mediate the formation of cell-cell contacts","volume":"83","author":"Cukierman","year":"2009","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2010.05.073_bib22","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1128\/JVI.00193-07","article-title":"High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein","volume":"81","author":"Catanese","year":"2007","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2010.05.073_bib23","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1128\/JVI.02460-05","article-title":"Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses","volume":"80","author":"Koutsoudakis","year":"2006","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2010.05.073_bib24","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20090766","article-title":"Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus re-infection in liver transplantation","author":"Fafi-Kremer","year":"2010","journal-title":"J Exp Med"},{"key":"10.1053\/j.gastro.2010.05.073_bib25","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1053\/j.gastro.2008.07.018","article-title":"Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion","volume":"135","author":"Haberstroh","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.05.073_bib26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo","volume":"132","author":"von Hahn","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.05.073_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1053\/j.gastro.2010.05.073_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2010.05.073_bib29","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/hep.22244","article-title":"Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain","volume":"47","author":"Vanwolleghem","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.05.073_bib30","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1084\/jem.20050122","article-title":"Divergent and convergent evolution after a common-source outbreak of hepatitis C virus","volume":"201","author":"Ray","year":"2005","journal-title":"J Exp Med"},{"key":"10.1053\/j.gastro.2010.05.073_bib31","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bpg.2008.12.004","article-title":"Liver transplantation in viral hepatitis: prevention of recurrence","volume":"22","author":"Roche","year":"2008","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2010.05.073_bib32","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1128\/JVI.00248-09","article-title":"Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity","volume":"83","author":"Keck","year":"2009","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2010.05.073_bib33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(91)92515-4","article-title":"Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients","volume":"337","author":"Samuel","year":"1991","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2010.05.073_bib34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/322043","article-title":"Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants","volume":"184","author":"Boeckh","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1053\/j.gastro.2010.05.073_bib35","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1200\/JCO.2003.12.109","article-title":"Pharmacokinetics, safety, and efficacy of trastuzumab administered every three weeks in combination with paclitaxel","volume":"21","author":"Leyland-Jones","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.gastro.2010.05.073_bib36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(07)61052-6","article-title":"HIV entry inhibitors","volume":"370","author":"Este","year":"2007","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2010.05.073_bib37","doi-asserted-by":"crossref","first-page":"12473","DOI":"10.1128\/JVI.01138-09","article-title":"Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus","volume":"83","author":"Broering","year":"2009","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2010.05.073_fr1","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.23445","article-title":"Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations","volume":"51","author":"Krieger","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.05.073_fr2","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/hep.21994","article-title":"Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81","volume":"46","author":"Zeisel","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.05.073_fr3","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1128\/JVI.76.16.8189-8199.2002","article-title":"Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro","volume":"76","author":"Castet","year":"2002","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2010.05.073_fr4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jmv.21043","article-title":"Development of a TaqMan assay for the six major genotypes of hepatitis C virus: comparison with commercial assays","volume":"80","author":"Engle","year":"2008","journal-title":"J Med Virol"},{"key":"10.1053\/j.gastro.2010.05.073_fr5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/JVI.01443-07","article-title":"Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent","volume":"82","author":"Molina","year":"2008","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2010.05.073_fr6","doi-asserted-by":"crossref","first-page":"21092","DOI":"10.1074\/jbc.M110.104836","article-title":"Claudin association with CD81 defines hepatitis C virus entry","volume":"285","author":"Harris","year":"2010","journal-title":"J Biol Chem"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508510008358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508510008358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T15:55:47Z","timestamp":1559145347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508510008358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0016508510008358"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2010.05.073","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}